These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
892 related articles for article (PubMed ID: 33955564)
1. A century of BCG: Impact on tuberculosis control and beyond. Ahmed A; Rakshit S; Adiga V; Dias M; Dwarkanath P; D'Souza G; Vyakarnam A Immunol Rev; 2021 May; 301(1):98-121. PubMed ID: 33955564 [TBL] [Abstract][Full Text] [Related]
2. Natural and trained innate immunity against Mycobacterium tuberculosis. Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788 [TBL] [Abstract][Full Text] [Related]
3. Low-dose Peralta Alvarez MP; Jones H; Redondo Azema H; Davis C; White AD; Sarfas C; Dennis M; Li S; Wright D; Puentes E; Kimuda S; Belij-Rammerstorfer S; Aguilo N; Martin C; Sharpe S; McShane H; Tanner R Front Immunol; 2024; 15():1387454. PubMed ID: 38799468 [TBL] [Abstract][Full Text] [Related]
4. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390 [TBL] [Abstract][Full Text] [Related]
5. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design. Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM Front Immunol; 2019; 10():2806. PubMed ID: 31849980 [TBL] [Abstract][Full Text] [Related]
6. BCG-induced protection: effects on innate immune memory. Netea MG; van Crevel R Semin Immunol; 2014 Dec; 26(6):512-7. PubMed ID: 25444548 [TBL] [Abstract][Full Text] [Related]
7. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
9. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. Butkeviciute E; Jones CE; Smith SG Future Microbiol; 2018 Aug; 13(10):1193-1208. PubMed ID: 30117744 [TBL] [Abstract][Full Text] [Related]
10. Trained innate immunity and resistance to Mycobacterium tuberculosis infection. Koeken VACM; Verrall AJ; Netea MG; Hill PC; van Crevel R Clin Microbiol Infect; 2019 Dec; 25(12):1468-1472. PubMed ID: 30807849 [TBL] [Abstract][Full Text] [Related]
11. Targeting innate immunity for tuberculosis vaccination. Khader SA; Divangahi M; Hanekom W; Hill PC; Maeurer M; Makar KW; Mayer-Barber KD; Mhlanga MM; Nemes E; Schlesinger LS; van Crevel R; Vankayalapati R(; Xavier RJ; Netea MG; J Clin Invest; 2019 Sep; 129(9):3482-3491. PubMed ID: 31478909 [TBL] [Abstract][Full Text] [Related]
12. Current status of new tuberculosis vaccine in children. Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369 [TBL] [Abstract][Full Text] [Related]
13. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine. Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B Front Immunol; 2018; 9():2371. PubMed ID: 30386336 [TBL] [Abstract][Full Text] [Related]
14. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400 [TBL] [Abstract][Full Text] [Related]